approval
saveLINZESS (LINACLOTIDE) — FDA approval
community read0 votes
Sponsor: ABBVIE. Form: CAPSULE. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalLINZESS (LINACLOTIDE) — FDA approvalNov 4, 2025 · 336d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJun 12, 2023 · 1212d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalAug 24, 2021 · 1869d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalApr 12, 2021 · 2003d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalSep 22, 2020 · 2205d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalMar 8, 2017 · 3499d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 25, 2017 · 3541d ago
- approvalLINZESS (LINACLOTIDE) — FDA approvalJan 6, 2017 · 3560d ago
same company · ±60 days · 6
- approvaldivalproex sodium DR: DEPAKOTE ER (DIVALPROEX SODIUM) — FDA approvalMay 12, 2016
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalMay 6, 2016
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalMay 6, 2016
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalApr 13, 2016
- approvalvenetoclax: VENCLEXTA (VENETOCLAX) — FDA approvalApr 11, 2016
- approvalIMBRUVICA (IBRUTINIB) — FDA approvalJun 27, 2016
comments(0)
5-min edit window · permanent after that